Clinical Trials Logo

Clinical Trial Summary

The use of oral targeted therapies draws new medical management but also new practices for the patients (compliance), their family and the healthcare professionals [1,2]. These therapies have sometimes heavy toxicity: side effects to identify, to treat, and for the patient to learn to manage. This situation underlines the importance of a therapeutic education to accompany this "learning" [3]. Nevertheless, in France, the therapeutic educational programs, built according to the "standards" of the therapeutic education (TE), are still very rare in cancer research [4]. In May 2012, a therapeutic educational program for these patients has been developed in the oncology department of the Teaching Hospital of Bordeaux through a multidisciplinary team. This program, dedicated to metastatic renal cancer patients treated by oral targeted therapies, becomes here an object of research: MODAP (action-research).


Clinical Trial Description

At the diagnosis, 25 to 30 % of renal cancer patients present a metastatic disease. The prognosis remains dark in spite of the advent of the targeted therapies from 2007. Actually, the use of oral targeted therapies, most of the time carried out on an outpatient basis (sunitinib in particular), draws new medical management but also new practices for the patients (compliance), their family and the healthcare professionals [1,2].

These therapies have sometimes heavy toxicity: side effects to identify, to treat, and for the patient to learn to manage. This situation underlines the importance of a therapeutic education to accompany this "learning" [3]. Nevertheless, the therapeutic educational programs, built according to the "standards" of the therapeutic education (TE), are still very rare in cancer research [4]: multiplicity of the pathology (a cancer, cancers), multiplicity of the patients' experiences, the difficulty of implementation? In May 2012, in front of the experience told by the patients and the professionals in the context of metastatic renal cancer, the members of the oncology department of the Teaching Hospital of Bordeaux, the therapeutic educational Federation, the Coordination Cancer Centre (3C), an anthropologist, an expert patient and a patient's association developed a therapeutic educational program for these patients [current approval].

This program, built on the model of the TE in France, becomes here an object of research: MODAP (action-research). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02896790
Study type Observational
Source University Hospital, Bordeaux
Contact
Status Completed
Phase N/A
Start date March 9, 2015
Completion date April 2017

See also
  Status Clinical Trial Phase
Completed NCT00692497 - Electronic Referral and Booking of Outpatient Day Case Surgery Compared With Traditional Referral Routines. N/A
Not yet recruiting NCT06395207 - A Short Period of Proactive Community Case Management (ProCCM) to Improve Early Care-seeking for Fever in Sierra Leone N/A
Completed NCT01296906 - Population Versus Practice-based Interventions to Increase Immunizations N/A
Completed NCT01074762 - Randomised Controlled Trial of Structured Personal Care of Type 2 Diabetes Mellitus N/A
Recruiting NCT04291534 - Quality of Life and Addiction Among Hospital Night Workers
Completed NCT06341738 - The Efficacy of Digital Educational Interventions on Parental HPV Knowledge and Attitude, and Their Children's Vaccination Rates N/A
Not yet recruiting NCT06408233 - Person-Centered Quality Measurement and Management in a System for Addictions Treatment in New York State (Project 3) N/A
Completed NCT04118452 - Achieving My Potential: A Randomized, Controlled Trial of a Telephone-Based Developmental Care Coordination System N/A
Completed NCT02053467 - Building Capacity for Specialized Services Through eConsultation N/A
Completed NCT03330509 - Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital N/A
Not yet recruiting NCT06184724 - Implementation Pilot of Preoperative CGA Before Major Surgery N/A
Completed NCT04837274 - Anderson Study 1 - Tart Cherry Study N/A